JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma: These results suggest that the newly identified JAK3-INSL3 fusion transcript is oncogenic, and it may contribute to constitutive JAK3 activation and lymphomagenesis in MF/SS CTCL.